Gonzalez A.Orozco-Aguilar J.Achiardi O.Simon F.Cabello-Verrugio C.2021-11-092021-11-092020-11International Journal of Molecular Sciences, Volume 21, Issue 21, Pages 1 - 181 November 2020 Article number 790416616596http://repositorio.unab.cl/xmlui/handle/ria/20819Indexación ScopusSevere acute respiratory syndrome coronavirus (SARS-CoV-2) has produced significant health emergencies worldwide, resulting in the declaration by the World Health Organization of the coronavirus disease 2019 (COVID-19) pandemic. Acute respiratory syndrome seems to be the most common manifestation of COVID-19. A high proportion of patients require intensive care unit admission and mechanical ventilation (MV) to survive. It has been well established that angiotensin-converting enzyme type 2 (ACE2) is the primary cellular receptor for SARS-CoV-2. ACE2 belongs to the renin-angiotensin system (RAS), composed of several peptides, such as angiotensin II (Ang II) and angiotensin (1-7) (Ang-(1-7)). Both peptides regulate muscle mass and function. It has been described that SARS-CoV-2 infection, by direct and indirect mechanisms, affects a broad range of organ systems. In the skeletal muscle, through unbalanced RAS activity, SARS-CoV-2 could induce severe consequences such as loss of muscle mass, strength, and physical function, which will delay and interfere with the recovery process of patients with COVID-19. This article discusses the relationship between RAS, SARS-CoV-2, skeletal muscle, and the potentially harmful consequences for skeletal muscle in patients currently infected with and recovering from COVID-19. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.enAngiotensin I (1-7)Angiotensin Converting Enzyme 2AlamandineArtículo10.3390/ijms21217904